Phase II Trial of Reduced Intensity Busulfan / Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with AML, MDS, and ALL
2014 ◽
Vol 20
(2)
◽
pp. S217-S218
Yi-Bin Chen
◽
Shuli Li
◽
Candice Del Rio
◽
Erin Coughlin
◽
Karen K. Ballen
◽
...
2020 ◽
Vol 26
(2)
◽
pp. 316-322
Jacopo Peccatori
◽
Sara Mastaglio
◽
Fabio Giglio
◽
Raffaella Greco
◽
Roberto Crocchiolo
◽
...
2013 ◽
Vol 19
(10)
◽
pp. 1453-1458
◽
Qaiser Bashir
◽
Hassan Khan
◽
Peter F. Thall
◽
Ping Liu
◽
Nina Shah
◽
...
2018 ◽
Vol 24
(11)
◽
pp. 2310-2315
◽
Chien-Ting Lin
◽
Po-Ren Hsueh
◽
Shang-Ju Wu
◽
Ming Yao
◽
Bor-Sheng Ko
◽
...
2007 ◽
Vol 82
(10)
◽
pp. 873-880
◽
Akiko M. Saito
◽
Masahiro Kami
◽
Shin-Ichiro Mori
◽
Yoshinobu Kanda
◽
Ritsuro Suzuki
◽
...
2015 ◽
Vol 84
(10)
◽
pp. 981-988
◽
G. L. Mancardi
◽
M. P. Sormani
◽
F. Gualandi
◽
A. Saiz
◽
E. Carreras
◽
...
2011 ◽
Vol 17
(2)
◽
pp. S291
Z. Al-Kadhimi
◽
Z. Gul
◽
R. Rodriguez
◽
W. Chen
◽
A. Mitchell
◽
...
2018 ◽
Vol 103
(3)
◽
pp. 522-530
◽
John Koreth
◽
Haesook T. Kim
◽
Paulina B. Lange
◽
Samuel J. Poryanda
◽
Carol G. Reynolds
◽
...
2003 ◽
Vol 9
(3)
◽
pp. 162-169
◽
Michael R. Bishop
◽
Jeannie Whit-Shan Hou
◽
Wyndham H. Wilson
◽
Seth M. Steinberg
◽
Jeanne Odom
◽
...
2003 ◽
Vol 9
(2)
◽
pp. 99-100
L. Bruckner
◽
R. Duerst
◽
M. Kletzel
Close
Export Citation Format
Close
Share Document
Close